Our results partially confirm this finding by showing that the expression of YTHDF2 is highly elevated in the PAAD samples in the TCGA-GTEx cohort and a GEO dataset (GSE15471) (P < 0.001). Here, YTHDF2 is linked to pancreatic adenocarcinoma.